Healthcare -
Medical - Pharmaceuticals - NASDAQ - US
$ 24.2201
1.67 %
$ 1.1 B
Market Cap
-10.74
P/E
1. INTRINSIC VALUE
Balance Sheet
LifeMD, Inc.
| Current Assets | 48.7 M |
| Cash & Short-Term Investments | 35 M |
| Receivables | 8.22 M |
| Other Current Assets | 5.51 M |
| Non-Current Assets | 23.7 |
| Long-Term Investments | 0 |
| PP&E | 6.4 |
| Other Non-Current Assets | 17.3 |
| Current Liabilities | 60.3 M |
| Accounts Payable | 16 M |
| Short-Term Debt | 8.95 M |
| Other Current Liabilities | 35.3 M |
| Non-Current Liabilities | 16.3 M |
| Long-Term Debt | 16.2 M |
| Other Non-Current Liabilities | 100 K |
EFFICIENCY
Earnings Waterfall
LifeMD, Inc.
| Revenue | 212 M |
| Cost Of Revenue | -29.9 M |
| Gross Profit | 242 M |
| Operating Expenses | 194 M |
| Operating Income | -16.1 M |
| Other Expenses | 2.74 M |
| Net Income | -18.9 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
LifeMD, Inc.
| Net Income | -18.9 M |
| Depreciation & Amortization | 9.49 M |
| Capital Expenditures | -11.5 M |
| Stock-Based Compensation | 12.2 M |
| Change in Working Capital | 12.6 M |
| Others | 24.2 M |
| Free Cash Flow | 5.98 M |
Wall Street Analysts Price Targets
LifeMD, Inc.
LFMDP has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
0.33%
DIVIDEND YIELD
0.555 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
LifeMD, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter
globenewswire.com
- 1 month ago
LifeMD to Participate in Three Investor Conferences During May
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May:
globenewswire.com
- 1 month ago
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.
seekingalpha.com
- 1 month ago
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy® directly within LifeMD's virtual care platform.
globenewswire.com
- 1 month ago
LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.
globenewswire.com
- 1 month ago
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.
globenewswire.com
- 2 months ago
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2025, to holders of record at the close of business on April 4, 2025.
globenewswire.com
- 3 months ago
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Steve Dechert - KeyBanc Brooks O'Neil - Lake Street Capital Markets Steven Valiquette - Mizuho Securities Alex Fuhrman - Craig-Hallum Capital Group Sarah James - Cantor Anderson Schock - B. Riley Securities Operator Good afternoon.
seekingalpha.com
- 3 months ago
LifeMD Reports Fourth Quarter 2024 Results
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 million Full-year cash flow from operations increased 99% to $17.5 million and generated positive full-year net cash flow Exited 2024 with over $35 million in cash Introduces 2025 guidance for consolidated revenue of $265 million to $275 million and consolidated adjusted EBITDA of $30 million to $32 million Conference call begins at 4:30 p.m. Eastern time today NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three and 12 months ended December 31, 2024.
globenewswire.com
- 3 months ago
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the KeyBanc Capital Markets Healthcare Forum being held virtually on March 18-19, 2025. Management will participate in a fireside chat on Tuesday, March 18th at 11:15 a.m. Eastern time and will hold one-on-one meetings throughout the conference.
globenewswire.com
- 3 months ago
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on March 10, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.
globenewswire.com
- 3 months ago
LifeMD® Announces Entry Into the Behavioral Health Market
Expansion to Include Teletherapy, Psychiatry and Medication Management Behavioral Health Offering to be Led by Industry Veteran Julian Cohen NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its expansion into the behavioral health market. This strategic move broadens LifeMD's service offerings to include teletherapy, psychiatry and medication management for common mental health conditions.
globenewswire.com
- 3 months ago
8. Profile
Summary
LifeMD, Inc. LFMDP
COUNTRY
US
INDUSTRY
Medical - Pharmaceuticals
MARKET CAP
$ 1.1 B
Dividend Yield
0.33%
Description
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Contact
236 Fifth Avenue, New York City, NY, 10001
https://www.lifemd.com
IPO
Date
Oct. 5, 2021
Employees
304
Officers
Ms. Maria E. Stan CPA
Chief Accounting Officer & Controller
Mr. Eric H. Yecies
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. Stefan Galluppi
Chief Innovation Officer
Mr. Nicholas P. Alvarez
Chief Acquisition Officer & Head of Customer Acquisition
Mr. Dennis Wijnker
Chief Technology Officer
Mr. Marc Benathen
Chief Financial Officer
Mr. James Porte
Senior Vice President of Patient Experience
Ms. Jessica Friedeman
Chief Marketing Officer
Mr. Shane Biffar
Chief Compliance Officer & Deputy General Counsel
Mr. Justin Schreiber
Chairman & Chief Executive Officer